{"DataElement":{"publicId":"2593228","version":"1","preferredName":"Adverse Event Action Type","preferredDefinition":"Action taken in response to an unwanted effect caused by a drug or therapy.","longName":"AE_ACT_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2013054","version":"3","preferredName":"Adverse Event Action","preferredDefinition":"Action taken in response to an unwanted effect caused by a drug or therapy. Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"AE_ACTION","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2184272","version":"1","preferredName":"Adverse Event","preferredDefinition":"An unwanted effect caused by a drug or therapy.  Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"Adverse Event","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-194E-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":"Change concept code to C41331 as C2861 is retired per EVS. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2183650","version":"1","preferredName":"Action","preferredDefinition":"a thing done.","longName":"Action","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Action","conceptCode":"C25404","definition":"A thing done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9AFFD26-23B2-08E4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-07","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BA4F51-3E42-45B9-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2593223","version":"1","preferredName":"Adverse Event Protocol Agent Action Type","preferredDefinition":"Set of numbered categories to represent possible actions taken in response to an adverse event to a study or protocol agent.","longName":"AE_PROT_AGT_ACT_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"36","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Study drug permanently discontinued","valueDescription":"Study drug permanently discontinued","ValueMeaning":{"publicId":"2593224","version":"1","preferredName":"Study drug permanently discontinued","longName":"2593224v1.00","preferredDefinition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Continuing or enduring over time, without fundamental or marked change._To stop or end, permanently or temporarily.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Permanent","conceptCode":"C160628","definition":"Continuing or enduring over time, without fundamental or marked change.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28712587-AA15-29BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28712587-AA2F-29BF-E044-0003BA3F9857","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"REEVESD","dateModified":"2007-02-01","deletedIndicator":"No"},{"value":"Study drug interrupted","valueDescription":"Study drug interrupted","ValueMeaning":{"publicId":"2593225","version":"1","preferredName":"Study drug interrupted","longName":"2593225","preferredDefinition":"Study drug interrupted","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28712587-AA3B-29BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28712587-AA55-29BF-E044-0003BA3F9857","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"REEVESD","dateModified":"2007-02-01","deletedIndicator":"No"},{"value":"Dosage increased","valueDescription":"Dosage increased","ValueMeaning":{"publicId":"2593226","version":"1","preferredName":"Dosage increased","longName":"2593226","preferredDefinition":"Dosage increased","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28712587-AA61-29BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28712587-AA7B-29BF-E044-0003BA3F9857","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"REEVESD","dateModified":"2007-02-01","deletedIndicator":"No"},{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28712587-AA87-29BF-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Dosage decreased","valueDescription":"Dose Reduced","ValueMeaning":{"publicId":"2562123","version":"1","preferredName":"Dose Reduced","longName":"2562123","preferredDefinition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BFB8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-22","modifiedBy":"KUMMEROA","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28712587-AA9C-29BF-E044-0003BA3F9857","beginDate":"2002-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"REEVESD","dateModified":"2007-02-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2593222","version":"1","preferredName":"Adverse Event Protocol Agent Action Type","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.:Action; a thing done.:Type; a subdivision of a particular kind of thing.","longName":"C41331:C41161:C25404:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Protocol Agent","conceptCode":"C41161","definition":"A medical product, practice, or application that is tested in a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Action","conceptCode":"C25404","definition":"A thing done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28712577-3F09-284B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"ONEDATA","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28712577-3F1A-284B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":"Permissible values and meanings support CMTS reporting requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812723","version":"1","longName":"ThermoDox Study","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"}],"ReferenceDocuments":[{"name":"AE Action","type":"Preferred Question Text","description":"AE Action","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"28713200-2892-2C7D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-02-01","modifiedBy":"MAESKEB","dateModified":"2013-09-11","changeDescription":"Curated to support Duke University ThermoDox protocol adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}